Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 30;21(9):2971-2976.
doi: 10.6026/973206300212971. eCollection 2025.

Correlation of serum adiponectin with thyroid profile among metabolic syndrome patients with and without hypothyroidism

Affiliations

Correlation of serum adiponectin with thyroid profile among metabolic syndrome patients with and without hypothyroidism

Selvakumar D et al. Bioinformation. .

Abstract

The Metabolic Syndrome is becoming a more significant global public health condition, and look for reliable, sensitive biomarkers that may be used as diagnostic tools to identify metabolic syndrome. Therefore, it is of interest to correlate the serum adiponectin with thyroid profile in metabolic syndrome patients with and without hypothyroidism. This is a cross-sectional study that included total 120 metabolic syndromes with and without hypothyroidism and 30 healthy controls. The analysis of biochemical and experimental parameters was done. The serum adiponectin was significant and drastically decreased levels was observed in metabolic syndrome patients with and without hypothyroidism and healthy controls (P = 0.001**). It was observed that serum adiponectin was negatively correlated with blood sugars, lipid profile, MDA, TSH and positively correlated with FRAP (P = 0.001**). Thus, we show significantly decreased levels of serum adiponectin among metabolic syndrome patients with and without hypothyroidism might be useful for identify complications like type 2 diabetes mellitus and cardiovascular diseases.

Keywords: Adiponectin; ferric reducing ability of plasma; malondialdehyde; metabolic syndrome.

PubMed Disclaimer

References

    1. Hosseini A, et al. Phytother Res. . 2021;35:5352. - PubMed
    1. Fu Y. Prog Mol Biol Transl Sci. . 2014;121:293. - PubMed
    1. Bajpai A, et al. Indian J Pediatr. . 2021;88:322. - PubMed
    1. Frankenberg A.D.V, et al. Arch Endocrinol Metab. . 2017;61:614. - PMC - PubMed
    1. Lopez-Jaramillo P, et al. Horm Mol Biol Clin Investig. . 2014;18:37. - PubMed

LinkOut - more resources